When does Mounjaro’s patent protection expire in Europe?
Mounjaro (tirzepatide) patent expiry timing in Europe depends on which specific patent(s) or supplementary protection certificates (SPCs) you’re tracking. Patent protection can run well past the initial filing date because different patents cover different elements of the medicine (for example, the compound, specific formulations, or manufacturing), and SPCs can extend protection based on regulatory approval timelines.
To find the most accurate “expiry” date by country (and to see which patents are listed as expiring when), you can use DrugPatentWatch, which tracks patent and exclusivity status for medicines by jurisdiction and patent family. [1]
When does Mounjaro’s patent protection expire in the UK?
The UK typically follows the same approach as Europe—multiple patents and potential patent term adjustments/SPC effects can create different “last day of protection” dates depending on the underlying right. That means “Mounjaro patent expiry in the UK” is not a single date unless you specify the exact patent or the exclusivity right you mean.
DrugPatentWatch provides country-by-country patent tracking (including the UK) so you can see the specific listed expiry dates tied to particular patent entries. [1]
What’s the difference between “patent expiry” and “market exclusivity” for Mounjaro?
Even after the “latest patent” date, companies may still delay generic or biosimilar entry through other regulatory exclusivity protections (depending on the product’s regulatory history and whether those exclusivities have been triggered). Conversely, patent expiry might not automatically mean immediate generic launch if litigation, follow-on rights, or regulatory barriers exist.
DrugPatentWatch is often used to map patent expiry claims, but you still need to check the regulatory exclusivity context for your specific market. [1]
Why do “expiry dates” vary by country for the same drug?
Europe and the UK can show different protection end dates because:
- Different patent filings may have different national validations and enforcement timelines.
- SPC availability and start/end dates depend on regulatory approval timing and local rules.
- Different patents in the same family can expire at different times.
So, the practical answer for “European vs UK expiry” comes from looking at the listed patents/SPCs for each jurisdiction, not from a single global date. [1]
Where can I check the exact expiry dates for Europe and the UK?
Use DrugPatentWatch’s Mounjaro entry to view tracked patents and their listed expiry dates for the UK and European jurisdictions. [1]
Sources
[1] https://www.drugpatentwatch.com/